These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33331904)

  • 21. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
    Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
    Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.
    Klemm P; Hudowenz O; Asendorf T; Dischereit G; Müller-Ladner U; Lange U; Tarner IH
    Clin Rheumatol; 2020 May; 39(5):1513-1520. PubMed ID: 31916106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National Register.
    Macfarlane GJ; Barnish MS; Pathan E; Martin KR; Haywood KL; Siebert S; Packham J; Atzeni F; Jones GT
    Arthritis Rheumatol; 2017 Nov; 69(11):2144-2150. PubMed ID: 28622461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gender difference in clinical manifestations and comorbidities in the patients with spondyloarthritis].
    Wen YQ; Jiang YT; Liu ZY; Huang CH; Chen QY; Chen HS; Pan YF; Gu JR
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):812-817. PubMed ID: 30893722
    [No Abstract]   [Full Text] [Related]  

  • 25. Flare in spondyloarthritis: Thresholds of disease activity variations.
    Godfrin-Valnet M; Puyraveau M; Prati C; Wendling D
    Joint Bone Spine; 2015 May; 82(3):192-5. PubMed ID: 25619155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis.
    Senabre Gallego JM; Rosas J; Marco-Mingot M; García-Gómez JA; Santos-Soler G; Salas-Heredia E; Pons-Bas A; Barber-Vallés X; Bernal-Vidal JA; Cano-Pérez C; García-Carrasco M; Flores-Pardo E;
    Rheumatol Int; 2019 May; 39(5):841-849. PubMed ID: 30899987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS).
    Macfarlane GJ; Rotariu O; Jones GT; Pathan E; Dean LE
    Ann Rheum Dis; 2020 Feb; 79(2):202-208. PubMed ID: 31662321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis.
    Castrejón I; Pincus T; Wendling D; Dougados M
    RMD Open; 2016; 2(2):e000235. PubMed ID: 27486525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
    Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
    Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
    Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L
    Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
    Di Carlo M; Lato V; Carotti M; Salaffi F
    Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study.
    Redeker I; Callhoff J; Hoffmann F; Marschall U; Haibel H; Sieper J; Zink A; Poddubnyy D
    Arthritis Res Ther; 2020 Sep; 22(1):210. PubMed ID: 32912264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis.
    Chung HY; Chui ETF; Lee KH; Tsang HHL; Chan SCW; Lau CS
    RMD Open; 2019; 5(2):e001008. PubMed ID: 31452930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study.
    Zhao S; Thong D; Duffield SJ; Hughes D; Goodson NJ
    Rheumatol Int; 2018 Mar; 38(3):375-381. PubMed ID: 29322342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
    Sayın S; Yurdakul FG; Sivas F; Bodur H
    Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body mass index is related with the presence of syndesmophyte in axial spondyloarthritis: Data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
    Kim SK; Choe JY; Lee SS; Shin K
    Mod Rheumatol; 2017 Sep; 27(5):855-861. PubMed ID: 27919202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.
    Marona J; Sepriano A; Rodrigues-Manica S; Pimentel-Santos F; Mourão AF; Gouveia N; Branco JC; Santos H; Vieira-Sousa E; Vinagre F; Tavares-Costa J; Rovisco J; Bernardes M; Madeira N; Cruz-Machado R; Roque R; Silva JL; Marques ML; Ferreira RM; Ramiro S
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 32144137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
    Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
    Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.